Metabolic Research Peptides · 60mg vial
GLP-4 Blend
Buy 3+, save 10% · Kit of 10, save 25%
The GLP-4 Blend pairs Retatrutide (20mg), a GLP-1/GIP/glucagon triple receptor agonist, with Tirzepatide (40mg), a dual GIP/GLP-1 receptor agonist, in a single vial.
It is intended for research into combined incretin-axis signalling, appetite regulation, insulin sensitivity and energy expenditure in metabolic models.
Composition & Purity
Retatrutide (LY3437943), Tirzepatide (LY3298176), Lyophilized powder
For research purposes only
Compound: Retatrutide (LY3437943) + Tirzepatide (LY3298176)
Concentration: 60mg lyophilized powder (Retatrutide 20mg / Tirzepatide 40mg)
Storage: Refrigerate at 2–8°C. Protect from light. Reconstitute with bacteriostatic water prior to use.
- Size
- 60mg vial
- Weight
- 60mg
Composition & Purity
Retatrutide (LY3437943), Tirzepatide (LY3298176), Lyophilized powder
Consult published literature for specific protocol parameters. For research purposes only.
For research purposes only. Not for human or veterinary use.